Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SYNPO |
| Upstream (Parents) |
|---|
| (<<) AKT3 → SYNPO |
| (<<) ARHGAP25 → SYNPO |
| (<<) GNG11 → SYNPO |
| (<<) IL1R1 → SYNPO |
| (<<) NNMT → SYNPO |
| (<<) NR3C1 → SYNPO |
| (<<) PPAP2A → SYNPO |
| (<<) SGK1 → SYNPO |
| Downstream (Children) |
|---|
| SYNPO → AKAP12 (>>) |
| SYNPO → CHST12 (>>) |
| SYNPO → CLDN5 (>>) |
| SYNPO → DUSP2 (>>) |
| SYNPO → EFEMP1 (>>) |
| SYNPO → FADS2 (>>) |
| SYNPO → FGF1 (>>) |
| SYNPO → FNBP1 (>>) |
| SYNPO → GRB7 (>>) |
| SYNPO → GSK3A (>>) |
| SYNPO → IGFBP7 (>>) |
| SYNPO → ITPR1 (>>) |
| SYNPO → JAK1 (>>) |
| SYNPO → KCTD12 (>>) |
| SYNPO → LAMB2 (>>) |
| SYNPO → MAP6D1 (>>) |
| SYNPO → MYLK (>>) |
| SYNPO → NGFR (>>) |
| SYNPO → NOL9 (>>) |
| SYNPO → PDE2A (>>) |
| SYNPO → PLA2G4C (>>) |
| SYNPO → RRP15 (>>) |
| SYNPO → SH3TC1 (>>) |
| SYNPO → SOX17 (>>) |
